Mrv0541 04051517092D 17 17 0 0 0 0 999 V2000 4.5923 -2.9518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8778 -3.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1633 -2.9518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1633 -2.1268 0.0000 N 0 3 0 0 0 1 0 0 0 0 0 0 2.4489 -3.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7344 -2.9518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.4489 -4.1893 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 5.3067 -3.3643 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 6.0212 -2.9518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.7357 -3.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.4894 -3.0288 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.0414 -3.6418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.8619 -3.5556 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 7.6289 -4.3563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.9645 -5.1100 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.8219 -4.1848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2088 -4.7368 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 3 5 1 0 0 0 0 5 6 2 0 0 0 0 5 7 1 0 0 0 0 1 8 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 12 14 1 0 0 0 0 14 15 1 0 0 0 0 14 16 1 0 0 0 0 16 17 1 0 0 0 0 10 16 1 0 0 0 0 M CHG 2 4 1 7 -1 M RAD 1 4 2 M END > M2MDB006348 > M2MDB > [N+]C(CCSCC1OC(O)C(O)C1O)C([O-])=O > InChI=1S/C9H15NO6S/c10-4(8(13)14)1-2-17-3-5-6(11)7(12)9(15)16-5/h4-7,9,11-12,15H,1-3H2,(H,13,14)/q+1/p-1 > QUDMRZABJLFLCP-UHFFFAOYSA-M > C9H14NO6S > 264.27 > 264.054183349 > 6 > 31 > 25.516731805126057 > 1 > 3 > 0 > 0 > (1-carboxylato-3-{[(3,4,5-trihydroxyoxolan-2-yl)methyl]sulfanyl}propyl)azaniumyl > -2.10 > -2.862882262209279 > -1.08 > 0 > 1 > 0 > 11.308592212670076 > 1.626919858940398 > -3.6587446413644464 > 133.11 > 68.80380000000001 > 6 > 1 > 2.69e+01 g/l > (1-carboxylato-3-{[(3,4,5-trihydroxyoxolan-2-yl)methyl]sulfanyl}propyl)ammonio > 0 > ECMDB24231 > S-ribosyl-L-homocysteine $$$$